Sang Young Ryu

809 total citations
18 papers, 349 citations indexed

About

Sang Young Ryu is a scholar working on Reproductive Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sang Young Ryu has authored 18 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 7 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sang Young Ryu's work include Ovarian cancer diagnosis and treatment (11 papers), BRCA gene mutations in cancer (4 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Sang Young Ryu is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), BRCA gene mutations in cancer (4 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Sang Young Ryu collaborates with scholars based in South Korea, United States and United Kingdom. Sang Young Ryu's co-authors include Joo‐Hyun Nam, Jae‐Weon Kim, Elizabeth Lowe, Tsveta Milenkova, Charles A. Leath, Richard T. Penson, Mariusz Bidziński, Laura Barker, David Cibula and Nicoletta Colombo and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Gynecologic Oncology.

In The Last Decade

Sang Young Ryu

17 papers receiving 336 citations

Peers

Sang Young Ryu

ONCOL

SURGE

Inês Vasconcelos Germany

Eleonora Palluzzi Italy

Ilaria Cuccu Italy

Heidi Godoy United States

M.Steven Piver United States

Elisabet Sanchez United Kingdom

Julie Irving Canada

A. Paglia Italy

Robert C. Squatrito United States

Hua-Hsi Wu Taiwan

Inês Vasconcelos Germany

Sang Young Ryu

121 ×0.6

ONCOL

172 ×0.9

84 ×1.0

45 ×0.7

SURGE

62 ×1.0

Citations per year, relative to Sang Young Ryu Sang Young Ryu (= 1×) peers Inês Vasconcelos

Countries citing papers authored by Sang Young Ryu

Since Specialization

Citations

This map shows the geographic impact of Sang Young Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang Young Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang Young Ryu more than expected).

Fields of papers citing papers by Sang Young Ryu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sang Young Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang Young Ryu. The network helps show where Sang Young Ryu may publish in the future.

Co-authorship network of co-authors of Sang Young Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Sang Young Ryu. A scholar is included among the top collaborators of Sang Young Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sang Young Ryu. Sang Young Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Scambia, Giovanni, Ricardo Villalobos-Valencia, Nicoletta Colombo, et al.. (2024). Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results. Journal of Clinical Oncology. 43(12). 1408–1416. 1 indexed citations

Leath, Charles A., Giovanni Scambia, Nicoletta Colombo, et al.. (2022). LB001/#1731 Late-breaking abstract presentation: overall survival by number of prior lines of chemotherapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer receiving olaparib treatment or non-platinum chemotherapy in SOLO3. A1.1–A1. 6 indexed citations

Penson, Richard T., Ricardo Villalobos-Valencia, David Cibula, et al.. (2020). Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial. Journal of Clinical Oncology. 38(11). 1164–1174. 195 indexed citations

Penson, Richard T., Ricardo Villalobos-Valencia, David Cibula, et al.. (2019). Olaparib monotherapy versus (vs) chemotherapy for germline BRCA-mutated (gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase III SOLO3 trial.. Journal of Clinical Oncology. 37(15_suppl). 5506–5506. 22 indexed citations

Gaffney, David K., Henry C Kitchener, Sang Young Ryu, et al.. (2016). Cervix Cancer Research Network (CCRN). International Journal of Gynecological Cancer. 26(9). 1690–1693. 7 indexed citations

Gaffney, David K., Gita Suneja, Sang Young Ryu, et al.. (2015). The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup. International Journal of Radiation Oncology*Biology*Physics. 92(3). 506–508. 11 indexed citations

Suneja, Gita, Monica Bacon, William Small, et al.. (2015). The Cervix Cancer Research Network: Increasing Access to Cancer Clinical Trials in Low- and Middle-Income Countries. Frontiers in Oncology. 5. 14–14. 9 indexed citations

Kang, Sokbom, Dae Chul Jung, Seung Cheol Kim, et al.. (2014). Frequent use of complex surgeries and survival outcomes in ovarian cancer patients: A propensity score analysis from the Korean Gynecologic Oncology Group.. Journal of Clinical Oncology. 32(15_suppl). 5537–5537. 1 indexed citations

Lee, Taek Sang, Jae‐Weon Kim, Tae Jin Kim, et al.. (2009). Ovarian preservation during the surgical treatment of early stage endometrial cancer: A nation-wide study conducted by the Korean Gynecologic Oncology Group. Gynecologic Oncology. 115(1). 26–31. 34 indexed citations

10.

Lee, Ki Heon, Byoung Gie Kim, Joo‐Hyun Nam, et al.. (2009). Clinicopathologic Characteristics of Malignant Germ Cell Tumors in the Ovaries of Korean Women. International Journal of Gynecological Cancer. 19(1). 84–87. 25 indexed citations

11.

Song, Yong Jung, et al.. (2009). Adenocarcinoma arising from the respiratory ciliated epithelium in a benign cystic teratoma of the ovary. Archives of Gynecology and Obstetrics. 280(4). 659–662. 4 indexed citations

12.

Ryu, Sang Young, Kidong Kim, Woo Sik Lee, et al.. (2009). Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines. Journal of Gynecologic Oncology. 20(1). 48–48. 6 indexed citations

13.

Kim, Kidong, et al.. (2008). Modalities for evaluation of tumor size in cervical cancer. Journal of Gynecologic Oncology. 19(3). 205–205. 1 indexed citations

14.

Ryu, Sang Young, et al.. (2006). A case of alveolar rhabdomyosarcoma of vulva. 17(4). 320–320. 1 indexed citations

15.

Ryu, Sang Young, et al.. (2004). Detection of Recurrence with FDG-PET Scan in Patients with Endometrial Cancer.. Obstetrics & Gynecology Science. 47(2). 295–299. 1 indexed citations

16.

Ryu, Sang Young, et al.. (2002). A Case of Endometriosis at the Site of Abdominal Scar following Cesarean Section and A Case of Parenchymal Pulmonary Endometriosis.. Obstetrics & Gynecology Science. 45(11). 2031–2034.

17.

Ryu, Sang Young, et al.. (2001). A Clinicopathologic Characteristics and Survival Analysis of 217 Cases of Epithelial Ovarian Cancer.. Korean Journal of Obstetrics & Gynecology. 43(9). 1604–1610. 1 indexed citations

18.

Ryu, Sang Young, et al.. (1999). Primary Endodermal Sinus Tumor of the Omentum. Gynecologic Oncology. 72(3). 427–430. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact